We fi nd that both disease incidence and disease prevalence are higher among Americans in age groups 55-64 and 70-80, indicating that Americans suffer from higher past cumulative disease risk and experience higher immediate risk of new disease onset compared with the English. In contrast, age-specifi c mortality rates are similar in the two countries, with an even higher risk among the English after age 65. We also examine reasons for the large fi nancial gradients in mortality in the two countries. Among 55-to 64-year-olds, we estimate similar health gradients in income and wealth in both countries, but for 70-to 80-year-olds, we fi nd no income gradient in the United Kingdom. Standard behavioral risk factors (work, marriage, obesity, exercise, and smoking) almost fully explain income gradients among those aged 55-64 in both countries and a signifi cant part among Americans 70-80 years old. The most likely explanation of the absence of an English income gradient relates to the English income benefi t system: below the median, retirement benefi ts are largely fl at and independent of past income, and hence past health, during the working years. Finally, we report evidence using a long panel of American respondents that their subsequent mortality is not related to large changes in wealth experienced during the prior 10-year period.
nternational comparisons of health outcomes have risen in importance as a method of gaining insight into social and economic determinants of health status. This is partly because some key institutions-such as the way health insurance or income security is provided-vary more systematically and perhaps exogenously across rather than within countries. In a recent, widely cited paper, we compared disease prevalence among middleaged adults 55-64 years old in England and in the United States (Banks et al. 2006) . Based on self-reported prevalence of seven important illnesses (diabetes, heart attack, hypertension, heart disease, cancer, diseases of the lung, and stroke), Americans were much less healthy than their English counterparts, differences that were large along all points of the socioeconomic status distribution.
Moreover, using biological markers of disease, we found similar health disparities between Americans and the English, suggesting that these large health differences are not simply a result of differential reporting of illness in the two countries. They also exist with equal force among both men and women ). Since we purposely excluded minorities (African Americans and Latinos in the United States and immigrants in England), these differences were not solely due to U.S. health issues in the African American or Latino populations or the growing immigrant population in England. Finally, these disparities in prevalence of chronic illness were not the consequence of differences between the two countries in conventional risk factors such as smoking, obesity, and drinking. Health disparities were essentially unchanged when we controlled for different levels of these risk factors in the United States and in England.
The previous analysis had several limitations. First, all health outcomes examined were based on disease prevalence limited to a relatively narrow age group: those aged 55-64. Second, even with an expansion into other age groups, comparisons of disease prevalence by themselves do not inform us about differences in the contemporaneous risk of disease or disease incidence in the two countries. Third, we ignored the most widely studied crossnational health marker in demographic and health research: mortality. These limitations are addressed in this article.
Although data on mortality, disease incidence, and disease prevalence in the two countries turn out not to be contradictory, they do raise some fundamental questions about how these distinct health outcomes are interrelated. We address these issues in two ways. First, we expand our prevalence portrait to an older age group-70-80 years old-to evaluate whether the English health advantage in chronic disease persists into older ages. Next, we investigate patterns of disease incidence more directly by documenting disease incidence in the United States and England for the same age groups.
In spite of higher rates of disease incidence and prevalence in the United States than in England, age-specifi c mortality rates are not dissimilar when people are in their 60s and are somewhat higher in England than in the United States after age 70. Higher rates of both disease prevalence and disease incidence in the United States are still consistent with similar life expectancies in the two countries if incident mortality upon diagnosis is greater in England than in the United States.
We also examine in this article the role of fi nancial resources in affecting mortality differences in England and the United States. The causal role played by individual and fi nancial resources in directly affecting mortality has always been controversial, a debate that has been renewed in recent years as demographers (Rogers, Hummer, and Nam 2000) , epidemiologists (Adler and Rehkopf 2008; Lynch et al. 2004) , economists (Smith 1999) , and sociologists (Mirowsky and Ross 2003) bring their alternative perspectives to this issue. Using panel data matched to national death indexes, we analyze determinants of mortality in both countries with an emphasis on the question of the comparative nature of income and wealth gradients in mortality. Since the seminal demographic work of Kitagawa and Hauser (1973) , the relationship between economic status and subsequent mortality has remained very controversial. The addition of excellent microdata panels, such as the Health and Retirement Survey (HRS) and the English Longitudinal Survey of Aging (ELSA), containing rich income and wealth modules linked to the subsequent death of their respondents is an important advance in quality of data.
This article is divided into four sections. The fi rst briefl y summarizes the data and major variables used in our analysis. The second section highlights salient comparative patterns in disease prevalence, disease incidence, and mortality in England and the United States. The third section contains empirical models that investigate the impact of economic, demographic, behavioral risk, and health status variables on comparative mortality in the two countries. The fi nal section summarizes our main conclusions.
DATA
In this article, we examine health differences for middle-aged and older people in England and the United States. The English-U.S. comparison is of interest for several reasons. First and foremost, with the advent of HRS and ELSA, the quality of microdata with bio markers and links to national death indexes is by far the best for simultaneously considering disease prevalence, incidence, and mortality. Moreover, work subsequent to our original paper confi rmed that the U.S. health disadvantage in disease applies when the United States is compared with many Western European countries (Avendano et al. 2009 ). As we show below, trends in mortality by age between the United States and England parallel those for many countries in the West.
For the United States, our research is based on the HRS, a nationally representative panel survey that currently includes over 20,000 people in the population aged 50 and older in the United States (Juster and Suzman 1995) . The HRS began in 1991 with its original cohort aged 51-61, and new cohorts have been subsequently added to maintain population representation of this age segment. Respondents are reinterviewed biennially.
For England, we use the ELSA, which contains around 12,000 respondents recruited from three separate years of the Health Survey for England (HSE), to provide a representative sample of the English population aged 50 and over. 1 The health data were supplemented by collection of baseline social and economic data in the fi rst wave of ELSA fi elded in 2002. Like the HRS, follow-ups for the ELSA are conducted every two years, and currently the fi rst three waves are in the public domain.
Both HRS and ELSA are known to have high-quality measurements of several dimensions of socioeconomic status-education, income, and wealth. Income is asked separately for both spouses for each of its major sub-components-earnings, pensions, social security or state pensions, and income from capital. A unique aspect of these surveys is that they both contain high-quality wealth modules using a comprehensive and detailed set of questions on the important components of wealth (Juster and Smith 1997) .
MEASUREMENT OF DISEASE PREVALENCE, INCIDENCE, AND MORTALITY
The health outcomes measured in this research are disease prevalence, disease incidence, and mortality. For the fi rst two, we restrict ourselves to diseases that can be comparably measured in the two countries. For prior lifetime prevalence, both the HRS and the ELSA collect data on individual self-reports of specifi c diseases of the general form, "Did a doctor ever tell you that you had . . . ." The specifi c diseases included are diabetes, hypertension, heart disease, heart attack, stroke, chronic lung diseases, and cancer. Because these questions are asked in each wave, prevalence as well as incidence 2 of disease can be calculated among panel participants as new onsets of disease are diagnosed as waves of the panel unfold. Although we cannot now look at biomarker-based measures of disease in the complete data used here, we know from our earlier study that biomarkers give us the same ranking of disease prevalence in the two countries.
Although questions on disease prevalence are quite similar in ELSA and HRS, there are some differences in implementation to keep in mind. In 2002, when the ELSA baseline information was collected, many HRS respondents had been panel members for up to 10 years. Questions about disease prevalence had been asked of these respondents up to fi ve times, and in each new wave, the respondent was asked to verify his or her previous diagnosis, if positive. The other major difference is that the HRS probes disease prevalence by asking about each disease separately, whereas the ELSA shows its respondents a list of diseases on a "show card" and then asks them to name chronic diseases they have. Especially for less serious chronic conditions, there is a legitimate question as to whether "show card" lists understate disease prevalence. We present some evidence on this issue later.
The mortality status of ELSA and HRS survey participants can be identifi ed in essentially two ways. First, the survey organization may fi nd that the respondent is deceased when it attempts to interview respondents for the next survey wave. Second, both ELSA and HRS are matched to each country's National Death Index, which includes information about the date and cause of death of all respondents, regardless of their participation in 1. The HSE is a series of annual health surveys beginning in 1991 covering the adult population aged 16 and over who live in private households in England. The contents of the core model vary by year. It has no panel component.
2. Although we use the term incidence throughout this article, a more accurate term is new detection.
subsequent waves of the survey. 3 These matches with the national death indexes are highly successful: more than 95% of individuals give permission for their records to be linked and are successfully matched. In this article, we concentrate on the mortality outcomes in two age groups-those 55-64 and those 70-80 years old in 2002-and limit our analysis to non-Hispanic whites in both countries so that the health disparities documented are not simply due to the health problems of minority groups in each country. with 5.9%), and cancer prevalence is 74% higher in the United States than in England (9.6% compared with 5.5%).
COMPARATIVE PATTERNS

Comparisons of Disease Prevalence and Incidence in the United States and in England
Given the sharp age gradient in disease, Table 1 shows prevalences that are not, surprisingly, much higher among those in their 70s as aging takes its inevitable toll. More importantly, we fi nd the same country ranking for those in their 70s: disease prevalence remains higher among Americans than the English. For cancer, diabetes, and heart problems, American excess disease is equally large in absolute value among those in their 70s.
Because they are computed from panel studies, disease prevalences in Table 1 based on the ELSA and the HRS contain potential sources of bias. As mentioned earlier, the ELSA obtained data using "show card" lists, and the HRS updated information obtained in previous waves. To check on the possibility that these potential biases could affect intercountry comparisons, Table 1 also lists estimates of disease prevalence obtained from the best cross-sectional health surveys in each country: the Health Survey for England (HSE) and the National Health Interview Survey (NHIS) in the United States. Although there are some differences between estimates obtained from the ELSA and the HRS and the cross-sectional "gold standards," the ranking of the countries remains intact: Americans are sicker than the English. The one large difference that emerges is hypertension prevalence in England, which is 4 or 5 percentage points higher in the HSE than in the ELSA. We believe that this may refl ect an understatement in the ELSA due to the use of "show cards" to measure prevalence, as discussed previously.
The fi fth and sixth rows in each age panel in Table 1 list 2002 disease prevalence in these age cohorts for those who remained in the survey in the two subsequent waves until 2006. Prevalence among respondents who neither died nor left the study are lower than prevalences in the fi rst row largely because of the higher levels of disease among those who died by 2006. However, this panel-sample-based estimate of disease prevalence also preserves the ranking of the two countries, with Americans still seen as much sicker than the English. Table 2 reports our measures of disease incidence. The fi rst measure involves computing disease incidence among those in the HRS and the ELSA who were interviewed in both 2002 and 2006. 4 The second is based on differences in prevalence between cross-sectional estimates of prevalence in which the synthetic cohort sample is allowed to age by four years (using the NHIS for the United States and the HSE for England).
Each alternative method has advantages and disadvantages. Within-panel estimates of incidence are for survivors only where surviving means that respondents neither died nor left the study between 2002 and 2006. Attrition from the study does not affect ranking of estimates based on changes in cross-section data. If these were closed cohorts, differences in cross-sectional prevalence allowing a cohort to age would not be biased estimates of incidence, on average. But these are not closed cohorts mostly because of mortality. 5 Since those who subsequently died had higher baseline prevalence, synthetic cohorts created from cross-sections will understate new incidence among survivors because baseline prevalence would be smaller if we measured prevalence only over a sample of survivors. Mortality is relatively low in the 55-to 64-year-old age group, so this age group will not be affected much by this bias, but that might not be true among those 70-80 years old. Table 2 shows that, regardless of the method used, incidence of disease is generally higher in the United States than in England among those in the age group 55-64. Americans in this age group not only suffer from higher past cumulative disease risk, as indicated by their higher disease prevalence, but they also experience higher immediate risk of new disease 4. There is no requirement that they also participated in the 2004 wave. 5. Another reason that it is not a closed cohort is new immigration or emigration, but this is likely to be small in these age groups. onset or incidence compared with the English. Estimates of incidence are much closer in the age group 70-80, with a slight edge toward higher incidence among Americans.
The primary exception to the rule relates to onset of hypertension within the panel. We speculate that this results from an understatement of hypertension prevalence in baseline ELSA due to the use of "show cards" with multiple disease categories. Respondents are asked to list all conditions but may well prioritize their major conditions at baseline. When they are asked in subsequent waves about conditions not mentioned in previous waves, these preexisting minor conditions, such as hypertension, will be reported. As a result, initial prevalence would be lower and subsequent incidence would be higher until the panel reaches maturity. Note that when we use the synthetic cohort estimation ("show cards" are not used in the HSE, which instead follows the HRS and NHANES methodology), hypertension onset is higher in the United States than in England.
Comparisons of Mortality in the United States and in England
Microdata from the HRS and the ELSA allow us to compare determinants of mortality at older ages in the two countries. A natural starting point is the degree to which mortality as revealed by these micro surveys matches mortality from the national death indices in both countries. 
Age
Survival Probability
HRS data on respondent mortality are remarkably close to those obtained from the U.S. life table (Arias 2004) . 7 At all ages 50 and above, the two mortality curves closely overlap, with the only difference being the larger random component in the survey data, especially at older ages when the numbers of living respondents in the HRS sample become relatively thin (see Figure 1 ). Over this age range, there does not appear to be any systematic difference between the national death registry and HRS-based estimates of the four-year probability of survival by age.
As demonstrated in Figure 2 , this close correspondence is not the case in England. After age 65, mortality among ELSA respondents is somewhat lower than mortality in the English national death index (from the U.K. Government Actuary Department). The most likely explanation for this discrepancy is that compared with the HRS, the ELSA is an immature survey in the sense that it has not yet reached a population-representative steady state. ELSA's baseline sample in 2002 was drawn from the noninstitutionalized population, thereby omitting those residing in nursing homes whose mortality prospects, especially at older ages, are higher than average. A similar bias existed in the original HRS sample of older respondents (Asset and Health Dynamics of the Oldest Old [AHEAD] sample of those aged 70-80 fi elded in 1993). Because respondents are subsequently followed into nursing homes in both the HRS and ELSA samples, this bias no longer exists in the older HRS sample but is still present in the ELSA.
Our aim is to contrast the pattern of older-age mortality in the two countries. Panel A of Figure 3 compares survival probabilities of those over 50 years old in England and the United States using country-specifi c national death indices as the yardstick, while panel B switches the metric to the two national household surveys-the ELSA and the HRS. Using national death indexes, the probability of dying is only slightly higher in the United States than in England before age 65. After age 70, however, mortality probabilities are higher in England than in the United States, and hence remaining life expectancy is lower. As indicated by the graphs in panel B, the patterns of roughly equal mortality between the two countries before age 65 is confi rmed by survey data. After age 65, the probability of death appears to be higher in the HRS than among ELSA respondents, even though we know from the national death indices that the opposite is the case.
At these ages, controlling for age, disease prevalence is higher in the United States than in England, as is new disease incidence; but the English have higher age-specifi c allcause mortality. Is it possible to reconcile higher rates of disease prevalence and disease incidence in the United States than in England alongside higher post-age-65 age-specifi c mortality in England? There are two possible explanations. The fi rst is that true incident mortality from disease is shorter in England than in the United States. The second is that true incident mortality is the same in both countries, but that the English are diagnosed at a later stage in the disease process than Americans are. 8 With the available data, we cannot separate the relative role played by these two factors, and it is most likely a combination of the two. Whatever the weights assigned to these explanations, both imply higher-quality medical treatment (broadly defi ned) in the United States than in England, at least in the sense that mortality implications of disease are less severe in the United States. A broad defi nition of quality treatment includes accurate and timely diagnosis; effective treatment of the disease; and good patient compliance with medication, personal behaviors, and follow-up visits and/or treatment.
Cancer is a good illustrative example. The United States is believed to screen and capture earlier in the progression of disease, particularly for prostate and breast cancer 7. The CDC life tables are for whites, while the HRS data are for non-Hispanic whites. Using HRS data for all whites yields similar results.
8. The delayed diagnosis of disease cannot be so severe that it is camoufl aging the data on disease prevalence because when we have biomarker data, the self-reported and biomarker-determined prevalences are similar-at least up to age 70 (see Banks et al. 2009 ). (Melia, Moss and Johns 2004; Preston and Ho 2009a; Sirovich, Schwartz, and Woloshin 2003) . Preston and Ho (2009a) reported higher fi ve-year cancer survival rates in the United States than in Europe, partly due to more aggressive screening. Our fi ndings are consistent with this evidence on cancer but can be extended, on average, to all-cause mortality. To the extent that increased screening intensity leads to discovery of milder and potentially less-fatal occurrences of disease, some part of this empirical relationship may not refl ect the direct consequences of health care interventions subsequent to diagnosis. But earlier detection could also be seen in this case as a good attribute of the medical system. A growing body of evidence suggests that the American disadvantage is that mortality declines pretty sharply with age. For example, Manton and Vaupel (1995) found that the United States had quite favorable survival over age 80 compared with other industrialized countries, including Japan. While spending for medical treatment has increased over time in the United States, these increases have been much larger (8% compared with 4.7% per year) among those over age 65 than among those aged 1-64 (Cutler and Meara 1998) . Moreover, these cost increases were concentrated among high-cost users-those with cardiovascular disease-which is consistent with a translation into mortality declines over time for those with cardiovascular disease in the United States. Preston and Ho (2009b) reported that among 18 OECD (Organisation for Economic Co-operation and Development) countries in 2005, the United States ranked last or next to last in life expectancy until after the mid-60s age range, after which it moved rapidly up the rankings into the top fi ve in survivor probabilities by the mid-80s in age. Preston and Ho concluded that the principal reason is that the American health care system performs well for older patients compared with other countries. Fonseca et al. (2009) estimated that technological change explains about 60% of the rise in life expectancy at age 50 over this period, while insurance access and income explained less than 10%.
Disease prevalence, disease incidence, and mortality are three interrelated but distinct measures of population health. The health problem in the United States is that Americans in adulthood become much sicker at much earlier ages than the English and many other Western Europeans do. Americans spend much more money dealing with this excess illnessmoney that, on average and increasingly, has payoffs in reduced mortality consequences of excess disease. The U.S. health problem is not fundamentally a health care quality or health insurance problem (though these factors are important, too). It is a problem of excess illness, the solution to which may lie primarily outside the health system.
MORTALITY MODELS
In this section, we present empirical models that investigate determinants of mortality at older ages. Our emphasis is on evaluating the nature of the mortality gradient with two key fi nancial measures-income and wealth-in England and the United States. We will evaluate how sensitive these fi nancial gradients are to the inclusion of sets of variables that may infl uence mortality and may also be correlated with the fi nancial situation of the household.
There are four models in Table 3 that are placed into four conceptually distinct blocks: (1) unadjusted or raw differences in mortality by fi nancial quintiles; (2) demographic models that add a full set of age and gender controls; (3) "behavior" models that add controls for other nonhealth behaviors that are widely accepted as related to mortality and to fi nancial gradients; and (4) models that control for baseline health status. All models include a set of dummy variables for either income quintiles or wealth quintiles.
To fi rst establish unadjusted differences in mortality, Model 1 contains only the fi nancial quintiles measures, with Quintile 1 representing the poorest 20% of the population, ranked by income and wealth, respectively, and with Quintile 5-the richest 20% of the population-being the omitted reference group. To assess the role of gender and age demographic differences, Model 2 adjusts for age by including single-year age dummy variables that are allowed to differ by gender. Model 3 adds a standard set of behavioral covariates that are known to be related to SES and to mortality. Some of these behavioral factors represent social relations, such as marital status (Jin and Christakis 2009; Waite and Gallagher 2000) ; some are alternative measures of SES, such as education; 9 some capture aspects of work, such as the two labor market status variables (whether the respondent is working and the number of weeks worked); and some represent a standard set of health behaviors measured in the two surveys (current smoking and previous smoking status, three categories of obesity [BMI of 30-35, BMI of 35-40, and BMI greater than or equal to 40], overweight 9. For the United States, the three education groups are less than high school, high school graduate but not a college graduate, and college graduate or more. We divide ELSA respondents into three education categories: those with a degree, or higher education below a degree, who are classed as "high"; those with A-levels, O-levels, or equivalent qualifi cations, who are classed as "moderate"; and those with qualifi cations below O-level, or no qualifi cations, who are classed as "low." (2) + Controls: Controls:
(2) + Controls: [BMI between 25 and 30], drinking, 10 and vigorous exercise 11 ). These variables we label behavior variables. Our interest here does not rest so much in differences among these alternative subtypes of behavioral variables, though they are important in their own right, but rather in their collective contribution to accounting for fi nancial gradients in health. The fi nal model adds a set of baseline health status measures, including three categorical variables for self-reported health status (whether respondent is in excellent or very good health, good health, or fair health, with the omitted group in poor health) and the following list of chronic health conditions: hypertension, diabetes, cancer, lung disease, heart disease, stroke, and arthritis. These variables, which we label the health status variables, are conceptually distinct from behavioral variables since they directly relate to the future health outcome being modeled. It is argued that controlling for baseline health status is necessary in order to estimate a causal effect of fi nancial resources on subsequent mortality since past health problems will directly affect the amount of fi nancial resources available to the household (Smith 1999 (Smith , 2004 . We return to this issue later. These models are estimated separately for each country for two age groups: ages 55-64 and 70-80. All models are estimated using ordinary least squares, and coeffi cients represent the estimated probability of dying over the four-year period.
The unadjusted income and wealth gradients for those 55-64 years old (Model 1) reveal that, in each country, the probability of death is 4 to 5 percentage points higher in the poorest income or wealth quintile than in the richest one. Even in these unadjusted variants, however, estimated gradients are highly nonlinear-much steeper below the median than above it. For example, mortality in the third and fourth income quintile in either country tends not to be statistically different than the top income quintile. Among those between ages 55 and 64, both income and wealth gradients are remarkably similar in the two countries, with perhaps a slightly higher excess mortality within the lowest income quintile in the United States.
This similarity in fi nancial gradients across countries is decidedly not the case for those between ages 70 and 80. In the United States, income and wealth gradients are much steeper than in the pre-retirement years and, while they remain highly nonlinear, the gradients do not disappear in quintiles above the median. In contrast, there is no income gradient at all in England in this age group, while a wealth gradient remains at least below median wealth. We return below to explanations for the absence of income gradients in the older group in England. Table 3 demonstrates that within these narrow age groups, including age and gender controls does not alter the nature of these estimated fi nancial SES gradients in either country. 12 In contrast, the addition of controls for health behaviors, work, and marital status signifi cantly reduces wealth and especially income mortality gradients. Among those 55-64 years old, there essentially remains a very weak income or wealth gradient, implying that this set of additional covariates placed under the behaviors label is suffi cient to account for most of the relationship of income or wealth to mortality. In contrast, the sharp between-country differences among those 70-80 years old remains-a reduction but not an elimination of both types of fi nancial gradients in the United States and a signifi cant 10. Heavy drinking in the United States is defi ned as drinking six or seven days a week, and in ELSA as at least daily. Moderate drinking is defi ned as one to fi ve days per week.
11. The question on vigorous exercise in the United States is, "On average over the last 12 months have you participated in vigorous physical activity or exercise three times a week or more? By vigorous physical activity, we mean things like sports, heavy housework, or a job that involves physical labor." In England, ELSA respondents are asked how often they engage in sports or activities that are vigorous in nature, "such as running or jogging, swimming, cycling, aerobics or gym workout, tennis, or digging with a spade or shovel." Those who reply that they do so once a week or more are given a value of 1; everyone else is given a zero.
12. If these models were estimated over the full age range from 50 to 80, the income gradient would be signifi cantly smaller when age controls are added because of the strong negative correlation between age and income. reduction of the wealth gradient in England. The nonexistent income gradient in England remains nonexistent.
The fi nal column for each country in Table 3 illustrates the effects on fi nancial gradients of adding health status controls. Once again, fi nancial gradients (both income and wealth) are either completely eliminated or, with the sole exception of wealth for Americans 70-80 years old, substantially reduced when baseline health status controls are added to the model. Table 4 (for ages 55-64) and Table 5 (for ages 70-80) contain distributions of selected attributes used as predictors in models in Table 3 . The fi rst and fourth columns are means of attributes in the lowest fi nancial quintile for the United States and England, respectively. The second and fi fth columns list differences between the third quintile and the fi rst, while the third and sixth columns contain differences between the highest and lowest quintile. We provide statistical tests of differences in attributes between these quintiles at the 5% level and the 1% level. The upper panels in these tables are arrayed by income quintiles, and the bottom panels are shown by wealth quintiles.
First, consider patterns observed among those 55-64 years old for behavior-related variables. Table 3 demonstrated that the behavior subset of variables was able to account for virtually all fi nancial gradients in mortality in both countries. This is not surprising because Table 4 shows that these behavior variables are all strongly socially graded in both countries.
While obesity declines with fi nancial quintiles, obesity alone contributes little to the observed fi nancial gradients in mortality, especially when compared with smoking. Current smoking declines rapidly across either income or wealth quintiles. In these birth cohorts in both countries and at all income and wealth levels, a large fraction of individuals who smoked in the past were able to stop. But the fact that current smoking declines more sharply across fi nancial gradients than does ever smoking implies that low-income and lowwealth individuals fi nd it much more diffi cult than higher-income or -wealth individuals to stop smoking once they have started. This pattern is especially true in England.
Exercise, work effort, and marriage are all graded and account for most of the attenuation of the fi nancial gradients when behavioral variables are added to the model. The extent of vigorous exercise increases rapidly with income and wealth, no doubt in part refl ecting differences across quintiles in health status of respondents. 13 Differences in the amount of work across these income quintiles are impressive. Low levels of work are partly the consequence of poor health and therefore primarily indicate causality from health to fi nancial resources (Smith 2004) . Those in the top U.S. quintile work 22 weeks more a year than those in the bottom income quintile; the comparable number in England is 25 weeks. A large part of that difference in work effort takes place at the bottom quintiles. The fraction of individuals who are married increases rapidly across these income and wealth quintiles. Table 5 contains a similarly structured distribution of attributes for ages 70-80. In these birth cohorts, unlike those born 15 years earlier, the probability of ever smoking does not vary with income. The probability of current smoking does decline with income and is primarily associated with the ability to stop smoking once started. Current smoking is much lower among these older respondents in both countries: 75% or more have ceased smoking. Not surprisingly, given that these are post-retirement years, the strong association of work with income quintile is much more muted in this age group. This is the primary reason for a smaller impact of these behavior variables on the size of fi nancial gradients in this age span.
Given the absence of an income gradient on mortality in England among those 70-80 years old, as shown in Table 3 , it is not surprising that health status outcomes in England are much less sharply graded than in the United States, especially along the income metric. In England, chronic diseases are as likely to rise with income quintile as to fall. In England, 13. The levels of vigorous exercise in the United States and England cannot be compared because of the differences in question wording in the two surveys. general health status is only 9 percentage points higher in the top income quintile compared with the bottom; the comparable differential in the United States is 25 percentage points.
Why Is There No Income Gradient in Mortality in England Among the Retired?
The most dramatic country-level difference in fi nancial gradients in mortality is the absence of any income gradient in England among those 70-80 years old. We believe this anomaly refl ects institutional differences between the two countries in the provision of income security during retirement. Specifi cally, compared with England, the state-provided pension in the United States (Social Security) is both a lower fraction of total retirement income and much more closely related to past labor market earnings and work (and thus past health status).
To understand how Britain's state benefi t system can decouple individuals' current income from their past income, in a way that the U.S. system does not, it is necessary to know a little about the benefi ts to which elderly people in England are entitled. The most important of these is the Basic State Pension (BSP), which makes up nearly a third of total government benefi t spending in Britain. The BSP is paid to individuals over the state pension age-currently 60 for women and 65 for men-and was worth £76 ($122) per week for a single pensioner and £121 ($194) per week for a couple in 2002-2003. Although not everyone qualifi es for the full rate of BSP (individuals must have made contributions to the National Insurance system for 90% of their working lifetime 14 ), coverage among pensioners-especially male pensioners-is very high. This makes the state pension a signifi cant source of income among 70-to 80-year-olds-and particularly so for those with below-average income. Figure 4 displays primary sources of income among the 14. Working lifetime is defi ned as the period between age 16 and the state pension age. While 90% of working life may seem a high bar to qualify for the benefi t, individuals are credited with National Insurance Contributions for periods out of the labor market due to illness, disability, or unemployment. 
Income Quintile
English in their 70s. Among individuals with income in the bottom six deciles, more than half their income comes from the state pension alone. Adding other state benefi ts accounts for more than three-quarters of their total income, on average, even around the median. 15 The fact that the BSP is an important component of older individuals' incomes, and that it is a mostly fl at-rate benefi t, offers the most plausible explanation for the absence of any income gradient for mortality among 70-to 80-year-olds in England. The comparatively generous benefi ts in England, especially at the bottom, act to reduce the link between income in retirement and poor health in earlier life. By eliminating the link between past health and income during retirement, one loosens the link between post-retirement income and subsequent mortality.
Several alternative explanations for the absence of a mortality gradient in income rely on types of selection effects that are correlated with income. One form of selection might be that "healthy survivor effects" are stronger in England. Poorer people in England who survive to the age of 70 or older may be healthier in unobservable ways than their higherincome counterparts. Were this the case, we would also expect to see no mortality gradient in other measures of socioeconomic status, such as wealth. As demonstrated in Table 3 , we see a robust wealth gradient in England in this age group, which argues against "healthy survivor" being a complete explanation.
Another form of selection may be survey-induced. As mentioned above, ELSA samples community residents at baseline, excluding those in nursing homes who are presumably less healthy. Why this would fl atten only the income gradient and not the wealth gradient remains a weakness of this selectivity explanation. The identical sampling bias was also present in the original AHEAD survey when it was fi elded (to those 70 and older in 1993) because it also was based on community residents. The income gradient in mortality in the AHEAD sample is quite strong.
A parallel question to why the income gradients in mortality are so low in England during these post-retirement years is why they are so high among Americans in this age group, even after we control for our subset of behavior variables. Our estimated U.S. gradients in Table 3 for those between ages 70 and 80 show that income gradients remain high until we control for baseline health status indicators.
Although a full accounting is beyond the scope of this paper, we present in Table 6 the income gradients presented in Table 3 . Alongside them, we list in parentheses estimated income gradients when we exclude income from capital. This source of income matters, especially for the lowest income quintile, for which the size of the excess mortality is cut by 40%. Income from capital is largely income earned from assets, and the amount of assets held is quite sensitive to past health occurrences (Smith 1999) . Poor health during one's life inhibits the ability to accumulate assets and thereby lowers the amount of asset income one has at any time. This empirically strong correlation between income and health most likely refl ects a pathway from health to income rather than the other way around.
Does Wealth Affect Mortality?
The fi nal models in Table 3 control for baseline measures of health status and fi nancial resources (income or wealth), and health status variables dominate fi nancial resources, which fail to predict subsequent mortality. Using the model in Table 3 , however, it is impossible to disentangle the complex pathways and interactions from the past that lead to the co existence of poor health outcomes and low levels of income or wealth. To estimate 15. Authors' calculations using Family Resources Survey. In addition to the state pension system, there are several benefi ts targeted at elderly people on low incomes. The most important is the Pension Credit Guarantee Element, which tops up incomes of individuals aged 60 and older to a specifi ed minimum level. Besides having incomes topped up, recipients of guarantee credit are automatically entitled to maximum amounts of several other benefi ts: housing benefi t, council tax benefi t, and health benefi ts such as free prescriptions, dental treatment, and sight tests. the effect of either on the other requires exogenous variation in health (or SES) that is not induced by SES (health). 16 In this section, we take a step in that direction by estimating pathways from fi nancial SES measures, and more particularly household wealth, to subsequent mortality. To do so, it is necessary to isolate innovations in household wealth that were not caused by health. To test whether changes in wealth affect subsequent health, one must have a panel that is suffi ciently long to capture wealth changes that are large enough both to alter a household's resources and to permit observation of any subsequent change in mortality. The best existing data panel to perform such a test is the original HRS cohort (those 51-61 years old in 1992). Those respondents have been interviewed for eight rounds over a 14-year period during a time span when large wealth changes occurred, mostly induced by asset price changes in housing and stock markets.
To conduct this analysis, we selected a sample of original HRS respondents who survived the full period (the period 1992-2002) over which we will measure wealth change. Our outcome variable is whether they survived until the end of 2006. Besides placing individuals into wealth quintiles, we placed them into fi ve quintiles based on their observed wealth changes between 1992 and 2002. All other variables in the models are the same as in the wealth analysis presented in Table 3 except that they are measured using the 1992 baseline values. 17 Quintiles of wealth (again defi ned at the initial 1992 baseline) are also included in all models. 18 Our estimated effects for wealth change variables are presented in Table 7 , which simply reports coeffi cients on the quintiles of change in wealth. Once again, the top quintilein this case those with the greatest accumulation of wealth between 1992 and 2002-is the omitted reference group. The format is similar to Table 3 , with parameter estimates listed fi rst with controls for age, gender, and the initial level of wealth only, then adding behavior variables, and fi nally adding the 1992 health status variables. The fi nal column in Table   16 . Smith (1999) proposed one research strategy for isolating new health events: the onset of new chronic conditions. To some extent, people may anticipate onset, but much of the actual realization and especially its timing may be unanticipated. While new onsets may provide the best chance of isolating health shocks, not all new onset is a surprise. A set of behavioral risk factors and prior health or economic conditions may make some people more susceptible than others to this risk. Thus, predictors of new onsets should be included in models to increase confi dence that the remaining statistical variation in new onsets is "news." 17. The drinking variables used in Table 3 Disease Prevalence, Disease Incidence, and Mortality in the U.S. and England S229 7 lists median wealth changes within each wealth change quintile to measure differences between groups. Changes in wealth are quite large even when medians are used: the difference between the bottom and top quintiles is over one-half million dollars, and changes in wealth expand as we move up the quintiles.
With the exception of the bottom quintile, estimated effects on mortality of the change in wealth are essentially zero in all specifi cations in spite of the $455,000 wealth change difference across 80% of the sample. There is no evidence across most of the sample that increases in wealth-even when large-are protective of subsequent mortality.
Those in the bottom wealth quintile have higher mortality compared with any other wealth change quintiles. But note that their wealth actually fell over this period. A more likely explanation for this result is that these individuals were hit by health shocks that led them to deplete their assets and wealth in order to fi nance their consumption, pay their medical bills, and perhaps to avoid asset tests in social programs.
At the very least, this analysis suggests that a great deal of caution is warranted in interpreting coeffi cients on wealth on health as an indication of a causal effect. More nuanced but complicated scenarios are still possible. Wealth effects may be very asymmetric: losses may have effects on health while gains do not. Similarly, wealth effects associated with a loss of a home may be quite different than simply loss of value in a home where one still lives.
CONCLUSIONS
In this article, we compare rates of disease prevalence, disease incidence, and mortality in England and the United States. We fi nd that disease incidence and prevalence are both higher among Americans in age groups 55-64 and 70-80, indicating that Americans not only suffer from higher past cumulative disease risk, as indicated by their higher disease prevalence, but also experience higher immediate risk of new disease onset or incidence compared with the English. In contrast, age-specifi c mortality rates are quite similar in the two countries, with an even higher risk among the English after age 65.
We also estimate fi nancial gradients in subsequent mortality in both countries and assess the sensitivity of these fi nancial gradients to the inclusion of "behavior" variables and baseline health status variables. We estimate similar gradients in both income and wealth among those 55-64 years old in both countries. In contrast, among those 70-80 years old, we estimate a signifi cant fi nancial gradient in both income and wealth in the United States but no income gradient in England. Standard behavioral risk factors (work, marriage, drinking, obesity, exercise, and smoking) almost fully explain income gradients among those 55-64 years old in both countries, and a signifi cant part of it among Americans 70-80 years old. If we also control for baseline health status, there are no remaining fi nancial gradients in either country in either age group. The most likely explanation of the absence of any income gradient among the English in their post-retirement years relates to the nature of their income benefi t system during retirement. Especially below the median, where the fi nancial mortality gradient tends to be steeper, these benefi ts are largely fl at and thus independent of past income during the working years, and are therefore largely independent of past health. Without that link to past health, there appears to be no effect of income on mortality in this age group in England.
Finally, using a long panel of respondents in the United States, we report evidence that Americans' subsequent mortality is not related to changes in wealth that they experienced during the prior 10-year period. This supports the view that the primary pathway between health and wealth is that poor health leads to a depletion of household wealth.
